BaraNova is a medical device company focusing on developing innovative nonsurgical, nonpharmacologic therapies for the treatment of obesity. BaroNova recently received funding to continue development of its novel obesity therapy and expects to rapidly enter into chronic animal studies followed by OUS human studies.
Financials
| Date | Type | Amount | Investors | Valuation |
|---|---|---|---|---|
| 01/01/07 | Seed | 3.5M | Unknown |
People
Hugh Narciso (President & CEO)
Competitors
ReShape Medical:
ReShape Medical, Inc. , headquartered in Southern California, is a development stage medical device manufacturer of… See Company Profile »
News
BAROnova pulls in funds for weight-loss tech
October 23, 2008 11:30 pm
Medical technology company BAROnova announced today that it brought in $7.5 million in a second round of funding led by… Continue reading ⟩